Who makes Viaskin Milk 300 mcg?

Viaskin Milk 300 mcg is developed by DBV Technologies.

What development phase is Viaskin Milk 300 mcg in?

Viaskin Milk 300 mcg is in Phase 1.

Last reviewed 2026-05-13 · How we verify

Viaskin Milk 300 mcg

DBV Technologies · Phase 1 active Biologic Quality 0/100

At a glance

Generic name	Viaskin Milk 300 mcg
Sponsor	DBV Technologies
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Viaskin Milk 300 mcg CI brief — competitive landscape report
Viaskin Milk 300 mcg updates RSS · CI watch RSS
DBV Technologies portfolio CI